Group | Number of axons per 0.05 mm2 ± SD (n of optic nerves) | p vs control | p vs iOHT injured eye | Brn3a-positive cells per mm retina ± SD (n of eyes) | p vs control | p vs iOHT injured eye | Iba1-positive cells per mm retina ± SD (n of eyes) | p vs control | p vs iOHT injured eye | IgG depositions per mm retina ± SD (n of eyes) | p vs control | p vs iOHT injured eye |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Control eyes | 22,267 ± 1408 (12) |  | 0.0003 | 95.2 ± 12.6 (13) |  | 0.0001 | 5.2 ± 1.1 (14) |  | 0.01 | 0.5 ± 0.4 (14) |  | 0.002 |
iOHT fellow eye | 21,943 ± 1510 (12) | 0.98 | 0.001 | 82.0 ± 9.9 (11) | 0.07 | 0.02 | 6.7 ± 1.3 (10) | 0.03 | 1 | 1.1 ± 0.4 (10) | 0.045 | 0.75 |
iOHT injured eye | 19,624 ± 1709 (12) | 0.0003 |  | 66.0 ± 13.2 (11) | 0.0001 |  | 6.7 ± 1.3 (12) | 0.01 |  | 1.3 ± 0.6 (10) | 0.002 |  |
iOHT + Belimumab fellow eye | 21,838 ± 802 (9) | 0.96 | 0.008 | 80.9 ± 10.0 (9) | 0.08 | 0.06 | 6.6 ± 1.0 (9) | 0.08 | 0.99 | 0.9 ± 0.2 (9) | 0.3 | 0.3 |
iOHT+ Belimumab injured eye | 20,593 ± 609 (9) | 0.07 | 0.5 | 74.2 ± 9.5 (8) | 0.005 | 0.6 | 6.5 ± 1.0 (8) | 0.1 | 0.99 | 0.9 ± 0.4 (8) | 0.3 | 0.4 |